Clinical Trials Browser

Phase 1/2 × Paraganglioma × Nivolumab × Clear all

NCT04187404 2026-01-30

Spencer

Phase 1/2 Terminated

70 enrolled 20 charts

Paraganglioma, Pheochromocytoma, Adrenocortical Carcinoma